White Paper

Adaptive Trial Design and Implementation WhitePaper

Source: Cytel
2 scientists in a lab

The Clinical Development of Drugs and devices is a challenging task, and more so than product development activity in most other industries. The technical challenges are huge because understanding of the biological systems involved is usually incomplete. The complexity is significant because patients vary significantly from
one another and are unpredictable in their responses. Additionally, every sponsor has to contend with the need for speed because of competition and the existence of budgetary pressures arising from the need to get a good return on investment in clinical development. The result is well known: success rates overall are low, New Drug Applications are too few, and the return on investment is abysmal.

Continue reading to understand the concept and benefits of adaptive trials and if they should be a consideration for your company.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader